Evaluating the time between cancer diagnosis and treatment is crucial as timely intervention improves survival rates, reduces patient anxiety and enhances treatment efficacy and efficiency. Participants to the roundtable will explore ways to ensure equitable access to care, improve cancer policy on this topic, and accelerate access to innovations in cancer treatment. The conclusions of the discussions will be synthetised in a future Policy Action Report.
The Roundtable will be co-chaired by Prof Peter Albers, Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ); and Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe.
Prof Peter Albers and Aleksandra Kaczmarek will introduce the concepts and themes of the roundtable. The introduction will also include a presentation from Zoë Parker, Policy Research and EU Projects Assistant, ECO European Cancer Pulse team.
Co-Chaired by Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe and Jose Luis Gomez Ruiz, Vice President, Public Policy and Advocacy Europe, Middle East and Africa, BD
Speakers and panellists will present and comment upon the role of digitisation in reducing waiting times from a variety of perspectives. Prof. Jesus Garcia-Foncilla, President, ECO Foundation will present the experience of the OncoOptimal project as a case study.
Co-chaired by Prof Peter Albers, Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
Speakers and panellists will present and comment upon the role of digitisation in reducing waiting times from a variety of perspectives. Prof. Jesus Garcia-Foncilla, President, ECO Foundation will present the experience of the OncoOptimal project as a case study.
To be co-chaired by Aleksandra Kaczmarek, Public Policy Manager, Digestive Cancers Europe and James Laubner, Director International Government Affairs - Europe, Canada, Mid-East, Africa and Latin America, Amgen
Rebecca Steele, Secretariat, European Alliance for Value in Health
Speakers and panellists will present and comment the role of early access schemes in providing patients with access to new treatments in accelerated time pathways. Mihai Rotaru, Director Market Access, at EFPIA will present the main results of the Patients W.A.I.T Indicator Survey series. Marie Phillips, from Tufts University School of Medicine will present recent research on multi-stakeholder perspectives on managing accelerated patient access to potentially beneficial medicines.